WSJ News Exclusive | Oxford-AstraZeneca Covid-19 Vaccine Startup in Conflict With University Ahead of Planned IPO
A startup behind the Covid-19 vaccine developed by the University of Oxford and AstraZeneca AZN 1.76% PLC is planning an...
A startup behind the Covid-19 vaccine developed by the University of Oxford and AstraZeneca AZN 1.76% PLC is planning an...
An experimental Covid-19 drug that promises to be a kind of Tamiflu for the pandemic had positive results in a...
TEL AVIV—The office security manager standing in the company cafeteria eyed a fellow-employee’s wrists, which lacked the new must-have accessory...
With vaccinations lagging in the world’s fourth most-populous country, the government has authorized an unusual approach: allowing private companies to...
The first single-dose Covid-19 vaccine, a shot from Johnson & Johnson, JNJ -2.64% was authorized for use, a big boost...
A committee of independent medical experts convenes Friday to review Johnson & Johnson’s JNJ 0.10% Covid-19 single-dose vaccine, the final...
Pfizer Inc. PFE -0.47% and BioNTech SE BNTX 1.96% have begun a study testing in people whether the companies’ Covid-19...
The pandemic travel bust that hit tourism-dependent economies may only just be beginning. Tourist destinations from Thailand to Iceland had...
Efforts to vaccinate the world’s population against Covid-19 got a boost Friday after research showed that some vaccines provide strong,...
U.S. workers have failed to return to the office in greater numbers this month, frustrating hopes that the rollout of...
Skowhegan, Maine—Pat and John Thomas were watching the news one night last week when they saw that Walmart in this...
As more Covid-19 vaccines become available in the U.S., it is getting tougher to run large clinical trials to test...
Forecasters are increasingly optimistic about economic growth this year, though less so about the labor market’s prospects, as it recovers...
Instagram removed the account of prominent vaccine skeptic Robert F. Kennedy Jr., one of the highest-profile steps in parent company...
Johnson & Johnson JNJ 0.93% asked U.S. regulators on Thursday to authorize the emergency use of its Covid-19 vaccine, setting...
Consulting giant McKinsey & Co. has reached a $573 million settlement with states over its work advising OxyContin maker Purdue...
McKinsey & Co. is close to reaching a settlement with state attorneys general over advice it gave to Purdue Pharma...